| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 03/17/2010 | EP2162439A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases |
| 03/17/2010 | CN101671315A New crystal form of febuxostat and preparation method thereof |
| 03/17/2010 | CN101671314A Uloric crystal and preparation method thereof |
| 03/16/2010 | US7678834 Substituted 4-aminocyclohexanol compounds |
| 03/16/2010 | US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 03/16/2010 | US7678810 activin receptor-like kinase 5 (ALK5) (which is a TGF- beta type I receptor) inhibitor ; glomerulonephritis, diabetic nephropathy, hepatic fibrosis, liver cirrhosis, pulmonary fibrosis, or alopeciarosis; hair growth stimulant |
| 03/16/2010 | US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV |
| 03/16/2010 | CA2372575C Bradykinin receptor antagonists |
| 03/16/2010 | CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein |
| 03/11/2010 | WO2010028338A2 Novel compounds as cannabinoid receptor ligands |
| 03/11/2010 | WO2010028132A2 Novel choline cocrystal of epalrestat |
| 03/11/2010 | WO2010027875A2 Compounds that modulate intracellular calcium |
| 03/11/2010 | WO2010027564A2 Amido anti-viral compounds, compositions, and methods of use |
| 03/11/2010 | US20100063095 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 03/11/2010 | US20100063051 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 03/11/2010 | US20100063041 Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same |
| 03/11/2010 | US20100061960 Amido Anti-Viral Compounds, Compositions, And Methods Of Use |
| 03/11/2010 | CA2738231A1 Novel choline cocrystal of epalrestat |
| 03/11/2010 | CA2734527A1 Novel compounds as cannabinoid receptor ligands |
| 03/11/2010 | CA2734500A1 Compounds that modulate intracellular calcium |
| 03/10/2010 | EP1556385B1 Heterocyclocarboxamide derivatives |
| 03/10/2010 | CN101665471A Preparation method of febuxostat intermediate |
| 03/09/2010 | US7674912 Phosphoric acid mono-{2-[(E/Z)-4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-benzoylimino]-thiazol-3-ylmethyl}ester; Parkinson's Disease; pro-drugs of A2A-receptor ligands with improved aqueous solubility |
| 03/09/2010 | US7674825 Cardiovascular disorders; stimulant of guanylate cyclase |
| 03/09/2010 | US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 03/09/2010 | CA2482346C Substituted phenylacetamides and their use as glucokinase activators |
| 03/09/2010 | CA2306313C Dipeptide nitriles |
| 03/04/2010 | WO2010025235A1 Selective ligands for the dopamine 3 (d3) receptor and methods of using the same |
| 03/04/2010 | WO2010024783A1 Biarylrhodanine and pyridylrhodanine compounds and their use |
| 03/04/2010 | WO2010024422A1 Amide compounds and use thereof |
| 03/04/2010 | WO2010024365A1 Amide compounds and use thereof |
| 03/04/2010 | WO2010023609A1 Oxazole, oxadiazole and thiazole derivatives as diacylglycerol acyltranferase inhibitors |
| 03/04/2010 | WO2010023448A1 Novel potassium channel blockers |
| 03/04/2010 | WO2010023445A1 Novel potassium channel blocker |
| 03/04/2010 | WO2009148269A3 Benzofluoranthene derivative and an organic luminescent element employing the same |
| 03/04/2010 | US20100056786 Method for Producing Alkylanilides from Halobenzene Derivatives |
| 03/04/2010 | US20100056579 Insecticidal n-substituted sulfoximines |
| 03/04/2010 | US20100056578 Insecticidal n-substituted sulfoximines |
| 03/04/2010 | US20100056503 Compounds for modulating integrin CD11b/CD18 |
| 03/04/2010 | US20100056469 Pesticidal Active Mixtures Comprising Aminothiazoline Compounds |
| 03/03/2010 | EP2159216A1 Ih - Modulators |
| 03/03/2010 | EP1558593B1 Transition metal catalysts for (co)polymerizing olefinic monomers |
| 03/03/2010 | EP1100801B1 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 03/02/2010 | US7671078 1,3-dicyclohexyl-2-(5,6-dihydro-imidazo[2,1-b]thiazol-3-ylmethyl)-isothiourea; 1,3-dicycloheptyl-2-(6,6-dimethyl-5,6-dihydroimidazo[2,1-b]thiazol-3-ylmethyl)-isothiourea; CXC chemokine Receptor |
| 03/02/2010 | US7671076 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 03/02/2010 | US7671051 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| 03/02/2010 | US7670991 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 02/25/2010 | WO2010021686A1 Luminogenic compounds and methods to detect cytochrome p450 3a enzymes |
| 02/25/2010 | WO2010020352A1 Compounds having electron transport properties, their preparation and use |
| 02/25/2010 | WO2009155001A3 Wnt protein signalling inhibitors |
| 02/25/2010 | WO2009110985A3 Amide compounds, compositions and uses thereof |
| 02/25/2010 | US20100048895 Process for Preparing Heterocyclic Derivatives |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
| 02/25/2010 | US20100048891 Metasubstituted thiazolidinones, their manufacture and use as a drug |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048570 Thiazolidine derivatives and methods for the preparation thereof |
| 02/25/2010 | US20100048453 Oxazole and thiazole ppar modulator |
| 02/24/2010 | EP2156833A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient |
| 02/24/2010 | EP2155893A2 Novel nitroreductase enzymatic substrates |
| 02/24/2010 | EP2155892A2 Novel peptidase substrates |
| 02/24/2010 | EP2155687A1 Diacylglycerol acyltransferase inhibitors |
| 02/24/2010 | EP2155675A1 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 02/24/2010 | EP1848705B1 Exo- and diastereo- selective syntheses of himbacine analogs |
| 02/24/2010 | EP1658066B9 Adamantylglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 02/24/2010 | CN101654443A Preparation method of 2, 2'-dibenzothiazyl sulfone |
| 02/24/2010 | CN101654442A 2-(2'-hydroxyphenyl) benzothiazole chelated zinc derivative as well as preparation method and application thereof |
| 02/24/2010 | CN100591679C Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/23/2010 | US7667044 treating nervous system diorders such as Alzheimer's disease, Down Syndrome, Parkinson disease and Huntington chorea by administering inhibitors of prolyl endopeptidases |
| 02/23/2010 | US7666987 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 02/23/2010 | US7666886 Compounds and methods for the diagnosis and treatment of amyloid associated diseases |
| 02/23/2010 | US7666885 Enzyme inhibitors |
| 02/23/2010 | US7666866 Antithrombotic diamides |
| 02/23/2010 | US7666865 Calcium channel blockers |
| 02/18/2010 | WO2010019828A1 Glucagon receptor antagonists |
| 02/18/2010 | WO2010019606A1 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
| 02/18/2010 | WO2010018874A1 Amide compound |
| 02/18/2010 | WO2010018714A1 Amide derivative, pest control agent containing the amide derivative and use of the pest control agent |
| 02/18/2010 | WO2009158374A3 Inhibitors of akt activity |
| 02/18/2010 | US20100041891 Amide compound |
| 02/18/2010 | US20100041723 Thiazole Compound (as PPAR delta) Ligand and Pharmaceutical, Cosmetic and Health Food Comprised Thereof |
| 02/18/2010 | US20100041711 Urea Glucokinase Activators |
| 02/18/2010 | US20100041708 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for it's preparation |
| 02/18/2010 | US20100041707 Inhibitors of ion channels |
| 02/18/2010 | US20100041694 Agricultural composition for controlling or preventing plant diseases caused by plant pathogenic microbes |
| 02/18/2010 | US20100041656 Novel amide derivatives and medicinal use thereof |
| 02/18/2010 | US20100040753 Flavor molecules |
| 02/18/2010 | CA2733966A1 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
| 02/18/2010 | CA2733557A1 Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative |
| 02/17/2010 | EP1558592B1 Thiazol-(bi)cycloalkyl-carboxanilides |
| 02/17/2010 | CN101652355A N- hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same |
| 02/17/2010 | CN101648926A Febuxostat crystal form and preparation method thereof |
| 02/17/2010 | CN101648925A 5-(4-chlorophenylmethyl)-4-tert-butyl-2-aminothiazolehydrobromate chiral crystal structure and preparation method thereof |
| 02/16/2010 | US7662971 enzyme inhibitor for treating sleep disorders |
| 02/16/2010 | US7662914 Native chemical ligation with three or more components |
| 02/16/2010 | US7662842 (4R)-2-(4-methoxyphenyl)-N-octadecylthiazolidine-4-carboxamide; antiacarcinogenic agent for destroying a melanoma cell |
| 02/16/2010 | US7662840 4-{5-[4-(5-Isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine or N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine (DW-1350); a leukotriene-B4 receptor antangonist; inhibiting osteoclastic bone absorption |
| 02/16/2010 | US7662839 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders; e.g. {4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl}-acetic acid |
| 02/16/2010 | US7662821 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 02/16/2010 | US7662771 Drug delivery; controlled/sustained release |
| 02/16/2010 | US7662750 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |